Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lantheus Holdings Inc LNTH

Healthcare Medical Instruments & Supplies
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus Hosts Inaugural Investor Day

GlobeNewswire May 16, 2022

Lantheus Presents Results from a PYLARIFY AI(TM) Study at the American Urological Association (AUA) Annual Meeting

GlobeNewswire May 16, 2022

Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients

GlobeNewswire May 13, 2022

Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Cancer

GlobeNewswire May 11, 2022

Lantheus to Present at the UBS Global Healthcare Conference

GlobeNewswire May 10, 2022

Lantheus Holdings, Inc. Reports First Quarter 2022 Financial Results

GlobeNewswire April 29, 2022

Lantheus Holdings to Host First Quarter 2022 Earnings Conference Call and Webcast on April 29, 2022 at 8:00 a.m. Eastern Time

GlobeNewswire April 15, 2022

Lantheus Appoints Jean-Claude Provost, MD as Interim Chief Medical Officer

GlobeNewswire April 4, 2022

Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development

GlobeNewswire March 29, 2022

Lantheus Holdings to Present at the Barclays Global Healthcare Conference

GlobeNewswire March 8, 2022

Lantheus to Host Inaugural Investor Day

GlobeNewswire March 3, 2022

Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member

GlobeNewswire March 1, 2022

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire February 24, 2022

Lantheus Receives U.S. FDA Approval of New Manufacturing Facility

GlobeNewswire February 23, 2022

Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU Meeting

GlobeNewswire February 10, 2022

Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on February 24, 2022 at 8:00 a.m. Eastern Time

GlobeNewswire February 10, 2022

Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabled Imaging Biomarkers in Prostate Cancer

GlobeNewswire January 27, 2022

Lantheus Appoints Vivian Yao as Chief Human Resources Officer

GlobeNewswire December 1, 2021

Lantheus Announces PYLARIFY AI(TM) is Now Available

GlobeNewswire November 29, 2021

Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F 18) Injection, Effective January 1, 2022

GlobeNewswire November 22, 2021